(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Palestinian leader Abbas says elections only after Gaza war ends - 2Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- 3Drones, physics and rats: Studies show how the people of Rapa Nui made and moved the giant statues – and what caused the island’s deforestation
- 4Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s
- 5Step by step instructions to Guarantee Your Lab Precious stone is Morally Obtained
- Vehicle Lovers' Decision: Purchase A Reasonable Vehicle
- Exploring the Main Year of Life as a parent: Individual Encounters
- Investigating Cooking and Culinary Expressions: An Excursion Through Flavors
- Last supermoon of the year, the cold moon, seen across the U.S.: See the photos
- 10 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- 6 Nations for Setting up camp
- Investigating the Medical advantages of Aloe Vera
- Step by step instructions to Pick the Right Dental specialist for Your Dental Inserts Technique
